HASTE与EPI-DWI在视网膜母细胞瘤中的比较及与预后组织病理学参数的相关性
本研究纳入21例初治视网膜母细胞瘤患者,行1.5T眼眶MR,比较EPI-DWI与HASTE-DWI的图像质量、信噪比、对比噪声比、几何变形及ADC值,并与组织病理预后标志物相关。HASTE-DWI整体图像质量更优,但肿瘤清晰度、SNR、CNR较低且采集时间更长;两种技术ADC值相关(r=0.8),有预后不良标志物的肿瘤ADC值较低但均未达统计学显著差异。
要点
- HASTE-DWI整体图像质量评分高于EPI-DWI(P<.01),但肿瘤清晰度评分EPI-DWI更高(P<.001)。
- EPI-DWI平均ADC为0.62±0.14×10⁻³ mm²/s,HASTE-DWI为0.83±0.17×10⁻³ mm²/s,两者相关(r=0.8;P=.01)。
- 有预后不良标志物的肿瘤ADC值较低,但均未达统计学显著差异。
核心结论
- HASTE-DWI整体图像质量改善,但在肿瘤清晰度、SNR、CNR和采集时间方面不及EPI-DWI;HASTE-DWI的ADC值在反映组织病理预后标志物方面较EPI-DWI无优势。
研究设计与样本
- 21例初治视网膜母细胞瘤患者行1.5T眼眶MR,采集3个b值(0、500、1000 s/mm²)的EPI-DWI和HASTE-DWI,所有患者随后行手术眼球摘除,以组织病理为参考标准。
关键影像表现/征象
- HASTE-DWI整体图像质量评分高于EPI-DWI(P<.01),但肿瘤清晰度评分EPI-DWI更高(P<.001)。
- HASTE-DWI的SNR、CNR和几何变形均低于EPI-DWI(P<.001)。
- EPI-DWI与HASTE-DWI平均采集时间分别约为1分钟和14分钟。
诊断标准与关键数值
- EPI-DWI平均肿瘤ADC值为0.62±0.14×10⁻³ mm²/s,HASTE-DWI为0.83±0.17×10⁻³ mm²/s。
- EPI-DWI与HASTE-DWI的ADC值显著相关(r=0.8;P=.01)。
- 有预后不良标志物的肿瘤ADC值较低,但均未达统计学显著差异。
临床应用与阅片要点
- HASTE-DWI整体图像质量较好,但肿瘤清晰度、SNR、CNR较低且采集时间较长,阅片时需权衡。
- HASTE-DWI的ADC值在反映组织病理预后标志物方面较EPI-DWI无优势。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND AND PURPOSE: Non-EPI-based DWI has shown better performance in head and neck pathologies owing to lesser susceptibility artifacts compared with EPI-DWI. However, only sporadic studies have investigated the feasibility of non-EPI-based DWI in retinoblastoma (RB). We qualitatively and quantitively compared EPI-DWI and HASTE-DWI in RB and correlated the tumor ADC values obtained from these 2 techniques with histopathologic markers.
MATERIALS AND METHODS: Twenty-one treatment-naive patients with RB underwent 1.5T orbital MR imaging. EPI-DWI and HASTE-DWI were acquired at 3 b-values (0, 500, and 1000 s/mm2). All patients subsequently underwent surgical enucleation. For qualitative image assessment, scoring of overall image quality, artifacts, tumor sharpness, and tumor conspicuity was done by using a 5-point Likert scale. Quantitative assessment included calculations of SNR, contrast-to-noise ratio (CNR), geometric distortion, and ADC. Qualitative scores were compared by using the Wilcoxon signed-rank test, and quantitative parameters were analyzed with a t test.
RESULTS: All 21 patients had unilateral RB; 15 were male and 6 were female with a median age of 36 months (range, 9-72 months). On histopathology, patients had either poorly differentiated (n = 13/21) or moderately differentiated (n = 8/21) RB. Other poor prognostic markers evaluated were optic nerve invasion (n = 10/21), choroidal invasion (n = 12/21), and anterior eye segment enhancement on MRI (n = 6/21). HASTE-DWI demonstrated higher image quality scores than EPI-DWI (P < .01), except for tumor conspicuity score, which was higher for EPI-DWI (P < .001). HASTE-DWI showed lower SNR, CNR, and geometric distortion than EPI-DWI (P < .001). The average acquisition times of EPI-DWI and HASTE-DWI were ∼1 and 14 minutes, respectively. The mean tumor ADC value on EPI-DWI was 0.62 ± 0.14 × 10-3 mm2/s and on HASTE-DWI was 0.83 ± 0.17 × 10-3 mm2/s. A significant correlation between EPI-DWI and HASTE-DWI ADC values (r = 0.8; P = .01) was found. Lower ADC values were found in tumors with poor prognostic markers, but none reached a statistically significant difference.
CONCLUSIONS: HASTE-DWI shows improved overall image quality; however, it lacks in terms of tumor conspicuity, SNR, CNR, and longer acquisition time compared with EPI-DWI. ADC values derived from HASTE-DWI show no advantage over EPI-DWI in correlation with histopathologic prognostic markers.
引用
- Sharma M, Gupta A, Jana M, et al. Comparison of HASTE versus EPI-Based DWI for Retinoblastoma and Correlation with Prognostic Histopathologic Parameters. AJNR Am J Neuroradiol. 2024. PMID: 38176729. doi:10.3174/ajnr.A8084
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。